Zhou Jing, Guo Xiaodong, Zheng Qixin, Wu Yongchao, Cui Fuzai, Wu Bin
Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China.
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, PR China.
Colloids Surf B Biointerfaces. 2017 Apr 1;152:124-132. doi: 10.1016/j.colsurfb.2016.12.041. Epub 2017 Jan 4.
An ideal bone substitute should be biocompatible, biodegradable, osteoinductive and osteoconductive. In our previous work, we fabricated a three-dimensional porous scaffold based on mineralized recombinant human-like collagen, nano-hydroxyapatite/recombinant human-like collagen/poly(lactic acid) (nHA/RHLC/PLA). Like other HA/collagen scaffolds, the nHA/RHLC/PLA scaffold lacked osteoinductive bioactivity. The purpose of the present study was to develop a polydopamine (pDA)-assisted BMP-2-derived peptide (designated as P24) surface modification strategy for improving the osteogenesis of the nHA/RHLC/PLA scaffold. The immobilization efficiency and release kinetics of P24, and in vitro osteoinductive activity of the nHA/RHLC/PLA-pDA-P24 scaffold were examined. The in vivo osteoinductive activity of the scaffold was evaluated usinga rat criticalsize calvarial defect model. Our results showed that pDA-assisted surface modification could more efficiently mediate the immobilization of P24 peptide onto the scaffold surfaces than physical adsorption. The in vitro release study showed that the P24 peptide was released slowly and steadily from the nHA/RHLC/PLA-pDA-P24 scaffold in a sustained manner, with a short initial burst release only during the first day, while the physisorbed nHA/RHLC/PLA-P24 group showed a sharp burst P24 release followed by a plateau phase. In vitro osteogenesis assay, the ALP activitiy and mRNA expression of osteo-specific markers of rat-derived mesenchymal stem cells (rMSCs) in the nHA/RHLC/PLA-pDA-P24 group were significantly higher than those of the nHA/RHLC/PLA-P24 and non-P24-loaded nHA/RHLC/PLA groups. In vivo, three-dimensional CT evaluation and histological examination demonstrated the nHA/RHLC/PLA-pDA-P24 scaffolds significantly enhanced bone regeneration of rat cranial defects to a much greater extent than physisorbed nHA/RHLC/PLA-P24 and non-P24-loaded nHA/RHLC/PLA scaffolds. Our findings indicated that the pDA-assisted surface modification method could significantly improve the osteogenesis activity of the nHA/RHLC/PLA scaffold and the new nHA/RHLC/PLA-pDA-P24 scaffold was a promising scaffold biomaterial for bone tissue regeneration.
理想的骨替代物应具有生物相容性、可生物降解性、骨诱导性和骨传导性。在我们之前的工作中,我们制备了一种基于矿化重组类人胶原蛋白、纳米羟基磷灰石/重组类人胶原蛋白/聚乳酸(nHA/RHLC/PLA)的三维多孔支架。与其他HA/胶原蛋白支架一样,nHA/RHLC/PLA支架缺乏骨诱导生物活性。本研究的目的是开发一种聚多巴胺(pDA)辅助的BMP-2衍生肽(命名为P24)表面修饰策略,以改善nHA/RHLC/PLA支架的成骨作用。检测了P24的固定效率和释放动力学,以及nHA/RHLC/PLA-pDA-P24支架的体外骨诱导活性。使用大鼠临界尺寸颅骨缺损模型评估了该支架的体内骨诱导活性。我们的结果表明,与物理吸附相比,pDA辅助的表面修饰能够更有效地介导P24肽固定到支架表面。体外释放研究表明,P24肽从nHA/RHLC/PLA-pDA-P24支架中持续缓慢稳定地释放,仅在第一天有短暂的初始爆发释放,而物理吸附的nHA/RHLC/PLA-P24组则显示出P24的急剧爆发释放,随后是平台期。在体外成骨试验中,nHA/RHLC/PLA-pDA-P24组大鼠来源间充质干细胞(rMSCs)的碱性磷酸酶活性和骨特异性标志物的mRNA表达显著高于nHA/RHLC/PLA-P24组和未负载P24的nHA/RHLC/PLA组。在体内,三维CT评估和组织学检查表明,nHA/RHLC/PLA-pDA-P24支架比物理吸附的nHA/RHLC/PLA-P24和未负载P24的nHA/RHLC/PLA支架能更显著地增强大鼠颅骨缺损的骨再生。我们的研究结果表明,pDA辅助的表面修饰方法可以显著提高nHA/RHLC/PLA支架的成骨活性,新型nHA/RHLC/PLA-pDA-P24支架是一种有前途的骨组织再生支架生物材料。